Case ReportInternational Journal of Advances in Medicine

Publication:
Rapidly progressing treatment resistant anti-TIF1 gamma antibody positive dermatomyositis

Int J Adv Med. 2022;9(3):342-345.DOI10.18203/2349-3933.ijam20220358

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Dermatomyositis is an idiopathic inflammatory myositis involving progressive muscle weakness with skin manifestations. Incidence of dermatomyositis is 1 per 100,000 in general population. Diagnosis is based on characteristic skin rashes, progressive muscle weakness and elevated muscle enzymes levels (creatine phosphokinase). The diagnosis is confirmed by clinical examination, abnormal electromyogram and autoimmune workup. In this case report, we report a case of difficult to treat dermatomyositis with proximal muscle weakness in an elderly male patient with classical skin lesions. The patient was resistant to steroid and immunoglobulin therapy.

Keywords

Affiliations

  1. Department of Medicine, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India
  2. Department of Rheumatology, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India

Full item record